Gufic Biosciences バランスシートの健全性
財務の健全性 基準チェック /56
Gufic Biosciencesの総株主資本は₹5.7B 、総負債は₹2.8Bで、負債比率は49.4%となります。総資産と総負債はそれぞれ₹11.0Bと₹5.3Bです。 Gufic Biosciencesの EBIT は₹1.3Bで、利息カバレッジ比率9です。現金および短期投資は₹194.0Mです。
主要情報
49.4%
負債資本比率
₹2.84b
負債
| インタレスト・カバレッジ・レシオ | 9x |
| 現金 | ₹193.96m |
| エクイティ | ₹5.74b |
| 負債合計 | ₹5.30b |
| 総資産 | ₹11.05b |
財務の健全性に関する最新情報
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17
These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13Recent updates
There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump
Nov 07We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings
Jun 06Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?
May 07Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 07This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid
Sep 15Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?
Aug 12Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest
Jun 11If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late
Mar 19What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?
Mar 01Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?
Jan 23
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company
Jan 05Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 18Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like
Dec 01Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?
Oct 19Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?
Sep 14I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut
Aug 24Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects
Aug 03Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)
Jul 09財務状況分析
短期負債: GUFICBIOの 短期資産 ( ₹5.8B ) が 短期負債 ( ₹3.5B ) を超えています。
長期負債: GUFICBIOの短期資産 ( ₹5.8B ) が 長期負債 ( ₹1.8B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: GUFICBIOの 純負債対資本比率 ( 46% ) は 高い と見なされます。
負債の削減: GUFICBIOの負債対資本比率は、過去 5 年間で123.8%から49.4%に減少しました。
債務返済能力: GUFICBIOの負債は 営業キャッシュフロー によって 十分にカバー されています ( 24.6% )。
インタレストカバレッジ: GUFICBIOの負債に対する 利息支払い は EBIT ( 9 x coverage) によって 十分にカバーされています。